Platform of Molecular Diagnosis. Unique, Simple and World Class.

Less than 10% of The world population has access to
Molecular Diagnosis.

Platform of Molecular Diagnosis.
Unique, Simple and World Class.

Less than 10% of The world population has access to
Molecular Diagnosis.

World-Class Molecular Diagnosis.

For everyone.

Everywhere.

For everyone.

Everywhere.

An integrated platform of Reagents, Hardware, and Software. High-tech with

versatility, flexibility, and simplicity.

The ability of Molecular Biology to accurately diagnose genetic and infectious diseases surpasses traditional clinical diagnosis.
But only 10% of the global population has access to this technology.

Limited Access

Molecular diagnosis is only available to a minority.

Only a few large laboratories centralize molecular diagnosis.

Complex Equipment

The equipment is difficult to operate and maintain.

Additionally, certain types of samples need to be sent abroad for analysis.

Expensive Solutions

Existing solutions require grouping hundreds of patients with the same disease to justify the cost.

IRIS® is an innovative and accessible technology for any laboratory.

Versatile

Can diagnose multiple genomic biomarkers simultaneously.

Flexible

Works efficiently with only 15 patient samples, testing 15 different diseases.

Adaptable

Up to 120 different samples simultaneously in multiples of 15.

Simple

It is easy to operate and maintain in any lab.

Scalable

Test results help create new products, more efficiently.

Unique

Highly sensitive and specific. Exclusive internal quality system.

Learn more about our platform

About Us

A combination of creative thinking and knowledge

ZEV Biotech was founded in 2017 in Argentina, achieving its initial milestones with the support of the “Ewald A. Favret” Institute of Genetics (IGEAF), and later establishing its presence at the Argentine Foundation of Nanotechnology.

Our History
Only 0%

of the global population has access to Molecular Diagnosis.

$0b

is the valuation of Molecular Diagnosis market in Latin America.

0%

will be the growth in the next decade.

At ZEV, we are shaping a future where cutting-edge Molecular Diagnosis is accessible to all laboratories and patients worldwide.

Contact Us

Research Institutes & Hospitals

Commercial Partners

Subsidies

Investors

+ 5 private investors